Showing 101 of 101on this page. Filters & sort apply to loaded results; URL updates for sharing.101 of 101 on this page
Agenus Collaborates with Zydus on BOT/BAL Development and U.S. BioCDMO ...
Agenus Receives $35M In Immuno-Oncology Transaction with Betta ...
Agenus Completes Strategic Collaboration with Zydus Lifesciences of ...
Agenus Announces Upcoming AACR 2026 Presentation Evaluating ...
Agenus Enters New Era With $141M Zydus Deal Signaling Strategic ...
Agenus surges after winning $1.6 billion deal from Bristol-Myers ...
Agenus continues partnership talks for anti-CTLA-4 combo with new Phase ...
Agenus Reports First Quarter 2024 Results | AGEN Stock News
Customer Story | Agenus
Agenus logo in transparent PNG and vectorized SVG formats
Agenus has Announced Five Presentations at 2025 ASCO GI Highlighting ...
Agenus 2025 results: BOT+BAL Phase 3, $4.2M access | AGEN Stock News
Agenus Shares Q3 2025 Milestones in Immunotherapy Progress - OncoDaily
Three decades of pioneering in Immune Oncology - Agenus - OncoDaily
Clinical Data Shows Survival Breakthrough for Agenus Cancer Drug Combo ...
Agenus to Reveal Phase 1 HCC Immunotherapy Data at AACR 2025 - OncoDaily
Agenus (AGEN) Stock Price & Overview
Agenus on the Rise Trailblazing Immunotherapy Innovations Set Stage for ...
AGEN - Agenus Inc Stock Price Forecast 2026, 2027, 2030 to 2050 - StockScan
Breakthrough Immunotherapy From Agenus (AGEN) Targets Toughest Tumors ...
Agenus CMO touts immunotherapy advances on The Top Line | Fierce Biotech
Agenus UK Ltd - Cambridge Science Park
Better Buy: Agenus Inc. vs. bluebird bio | Fox Business
Find out more about immunotherapy with Agenus - OncoDaily
Agenus Earnings Date Set: Q2 2025 Results Plus Strategic Update Coming ...
Agenus Stock Soars 11.28% on Immuno-Oncology Optimism
Agenus Reveals Enhanced Phase 1 Outcomes and Advances in MSS CRC ...
Agenus and Noetik Collaboration Will Predict Cancer Biomarkers Using ...
Agenus Corporate Deck & Trade Show Booth — Kim Althausen - Graphic ...
Agenus logo in transparent PNG format
Agenus Stock: 2024 May Finally Be The Year For A Major Turnaround ...
Agenus announced updated Phase 1 data and progress botensilimab ...
Agenus Inc (AGEN) Reports Full Year and Q4 2023 Financial Results ...
Agenus announced new data highlighting BOT/BAL across multiple lines of ...
Agenus Inc. (AGEN) Stock Price, News, Quote & History - Yahoo Finance
Agenus 與 Zydus 合作推進癌症免疫治療，擴大美國生產與亞洲授權 – 三嘻行動哇 Yipee!
Agenus CMO touts immunotherapy advances on The Top Line - The Top Line ...
Agenus (AGEN) Rises on Fast Track Tag for Cancer Combo Drug
Here is What to Know Beyond Why Agenus Inc. (AGEN) is a Trending Stock
Agenus - CTEP has announced the availability of botensilimab for ...
Agenus Closes Strategic Immunotherapeutic Collaboration with Zydus ...
Agenus Pushes Frontiers Compassionate Access, Global Trials, and AI ...
How Does Agenus Company Work? – SWOTTemplate.com
Agenus Presented New Translational Data at the ASCO 2025 - OncoDaily
Imunoterapia contra o Câncer: Agenus Announces Positive Interim Data ...
Agenus Hosts First 2026 Stakeholder Webcast on Global Access and ...
What is Immunotherapy? - Agenus - OncoDaily
Agenus Stock Surges on Promising Phase II Cancer Drug Data
AGEN Stock Price, News & Analysis | Agenus
Agenus Applauds FDA for Expanding the Priority Review Voucher Program ...
Agenus Advances Portfolio with 6 Clinical Collaborations - Sangri Today ...
Agenus Doses First COVID-19 Patient with iNKT Cell Therapy
Agenus Responds to New Regulatory Environment at FDA - OncoDaily
Biotech Agenus acquires 120 acres in biomanufacturing center in ...
아제너스(AGEN) 업데이트 내용 Agenus Inc. : 네이버 블로그
Future Tech investment articles generated using Ai technology : Agenus ...
Agenus Shared Q1 2025 Financial Results and Immuno-Oncology Pipeline ...
Agenus and Noetik Enter Collaboration to Develop AI-Enabled Pred
FDA Grants Priority Review to Agenus’ Balstilimab | Modality Solutions
Agenus, Zydus Finalize Strategic Immunotherapy Collaboration - Pharma ...
AGENUS: FDA Clears IND for iNKT Cells to Treat COVID-19 Patients | FDA ...
Agenus: Better immunotherapies
重磅！贝达药业与美国Agenus达成合作 引进PD-1和CTLA-4抗体项目
BOT/BAL Advancements, BATTMAN Trial, FDA Approval Challenges and Key ...
【即時新聞】Agenus攜手Zydus完成1.41億美元合作案加速抗癌免疫療法開發 | CMoney投資網誌
Slide 15
Future of Agenus’ Immunotherapy Combo Uncertain as FDA Discourages ...
Slide 29
LOGO
Future Tech articles generated using Ai technology
FDA grants fast track status to Agenus’ colorectal cancer combination ...
ESMO 2023: Agenus’ Botensilimab/Balstilimab Combination Delivers ...
Agenus, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
.png?width=5000&height=3750&name=Agenus%20(1).png)
